Trends in glycolipid biomarker discovery in neurodegenerative disorders by mass spectrometry

NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537 · see citing works

Principles of biochemistry

(1978) · Biochemical Education · doi:10.1016/0307-4412(78)90049-3 · Cited by 5,073 · see citing works

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135 · see citing works

Guillain-Barré syndrome

Hughes, R. A., & Cornblath, D. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67665-9 · Cited by 1,679 · see citing works

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341 · see citing works

The International Journal of Developmental Biology

Aréchaga, J. (2012) · Dialnet (Universidad de la Rioja) · Cited by 1,279 · see citing works

Journal of Psychiatry and Neuroscience

(2025) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn · Cited by 1,132 · see citing works

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · Science · doi:10.1126/science.1082324 · Cited by 879 · see citing works

Non‐motor symptoms in Parkinson’s disease

Poewe, W. H. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02056.x · Cited by 790 · see citing works

A new subtype of frontotemporal lobar degeneration with FUS pathology

Neumann, M., Rademakers, R., Roeber, S., Baker, M., Kretzschmar, H. A., & Mackenzie, I. R. A. (2009) · Brain · doi:10.1093/brain/awp214 · Cited by 722 · see citing works

ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?

Kanekiyo, T., Xu, H., & Bu, G. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.045 · Cited by 608 · see citing works

Phenotype, diagnosis, and treatment of Gaucher's disease.

Grabowski, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61522-6 · Cited by 582 · see citing works

Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains

Gegg, M. E., Burke, D., Heales, S., Cooper, J., Hardy, J., Wood, N., & Schapira, A. (2012) · Annals of Neurology · doi:10.1002/ana.23614 · Cited by 551 · see citing works

GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease

Yanagisawa, K., Odaka, A., Suzuki, N., & Ihara, Y. (1995) · Nature Medicine · doi:10.1038/nm1095-1062 · Cited by 544 · see citing works

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease

Murphy, K. E., Gysbers, A. M., Abbott, S. K., Tayebi, N., Kim, W. S., Sidransky, E., Cooper, A., Garner, B., & Halliday, G. M. (2014) · Brain · doi:10.1093/brain/awt367 · Cited by 475 · see citing works

Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin

Grimm, M. O. W., Grimm, H. S., Pätzold, A. J., Zinser, E. G., Halonen, R., Duering, M., Tschäpe, J., Strooper, B. D., Müller, U., Shen, J., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1313 · Cited by 446 · see citing works

Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects

Sheikh, K. A., Sun, J., Liu, Y., Kawai, H., Crawford, T. O., Proia, R. L., Griffin, J. W., & Schnaar, R. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7532 · Cited by 396 · see citing works

Functional Role of Glycosphingolipids in Cell Recognition and Signaling

Hakomori, S., & Igarashi, Y. (1995) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124992 · Cited by 395 · see citing works

A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease

Hughes, T. A., Ross, H., Musa, S., Bhattacherjee, S., Nathan, R. N., Mindham, R. H. S., & SPOKES, E. G. S. (2000) · Neurology · doi:10.1212/wnl.54.8.1596 · Cited by 372 · see citing works

Parkinsonism among Gaucher disease carriers

Göker-Alpan, Ö., Schiffmann, R., LaMarca, M. E., Nussbaum, R. L., McInerney-Leo, A. M., & Sidransky, E. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024455 · Cited by 366 · see citing works

Prevalence of orthostatic hypotension in Parkinson's disease

Sénard, J., Rai, S., Lapeyre‐Mestre, M., Brefel‐Courbon, C., Rascol, O., Rascol, A., & Montastruc, J. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.5.584 · Cited by 365 · see citing works

Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer’s disease

Kar, S., Slowikowski, S. P. M., Westaway, D. A., & Mount, H. T. J. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0442 · Cited by 363 · see citing works

Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

Tayebi, N. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00071-4 · Cited by 327 · see citing works

Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II)

Svennerholm, L. T., & Gottfries, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031039.x · Cited by 327 · see citing works

Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation

Dettmer, U., Newman, A. J., Soldner, F., Luth, E. S., Kim, N. C., von Saucken, V. E., Sanderson, J. B., Jaenisch, R., Bartels, T., & Selkoe, D. (2015) · Nature Communications · doi:10.1038/ncomms8314 · Cited by 317 · see citing works

Thematic Review Series: Sphingolipids. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease—a review

Ariga, T., McDonald, M. P., & Yu, R. K. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800007-jlr200 · Cited by 317 · see citing works

Acceleration of Amyloid Fibril Formation by Specific Binding of Aβ-(1–40) Peptide to Ganglioside-containing Membrane Vesicles

Choo, L.-P., Garzon-Rodriguez, W., Glabe, C. G., & Surewicz, W. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.22987 · Cited by 312 · see citing works

Non-pharmacological interventions in dementia

Douglas, S., James, I. A., & Ballard, C. G. (2004) · Advances in Psychiatric Treatment · doi:10.1192/apt.10.3.171 · Cited by 299 · see citing works

Membrane Lipids of Adult Human Brain: Lipid Composition of Frontal and Temporal Lobe in Subjects of Age 20 to 100 Years

Svennerholm, L. T., Boström, K. B., Jungbjer, B., & Olsson, L. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051802.x · Cited by 294 · see citing works

Tau PET imaging: present and future directions

Saint‐Aubert, L., Lemoine, L., Chiotis, K., Leuzy, A., Rodriguez‐Vieitez, E., & Nordberg, A. K. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0162-3 · Cited by 283 · see citing works

Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.

Dekker, N., van Dussen, L., Hollak, C., Overkleeft, H., Scheij, S., Ghauharali, K., van Breemen, M. V., Ferraz, M. J., Groener, J., Maas, M., et al. (2011) · Blood · doi:10.1182/blood-2011-05-352971 · Cited by 277 · see citing works

Interface between tauopathies and synucleinopathies: A tale of two proteins

Galpern, W. R., & Lang, A. E. (2006) · Annals of Neurology · doi:10.1002/ana.20819 · Cited by 262 · see citing works

GM1 Specifically Interacts with α-Synuclein and Inhibits Fibrillation

Martinez, Z., Zhu, M., Han, S., & Fink, A. L. (2007) · Biochemistry · doi:10.1021/bi061749a · Cited by 261 · see citing works

Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease

Kotagal, V., Albin, R. L., Müller, M. L. T. M., Koeppe, R. A., Chervin, R. D., Frey, K. A., & Bohnen, N. I. (2011) · Annals of Neurology · doi:10.1002/ana.22691 · Cited by 250 · see citing works

Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease

Taguchi, Y. V., Liu, J., Ruan, J., Pacheco, J., Zhang, X., Abbasi, J., Keutzer, J. M., Mistry, P. K., & Chandra, S. S. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1525-17.2017 · Cited by 244 · see citing works

Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease

Magalhães, J., Gegg, M. E., Migdalska‐Richards, A., Doherty, M. K., Whitfield, P. D., & Schapira, A. H. V. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw185 · Cited by 234 · see citing works

Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent‐resistant membrane domains

Molander‐Melin, M., Blennow, K., Bogdanović, N., Dellheden, B., Månsson, J., & Fredman, P. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02849.x · Cited by 224 · see citing works

Interactions of Amyloid β-Peptide (1−40) with Ganglioside-Containing Membranes

Matsuzaki, K., & Horikiri, C. (1999) · Biochemistry · doi:10.1021/bi982345o · Cited by 217 · see citing works

Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotes

Alcalay, R. N., Dinur, T., Quinn, T., Sakanaka, K., Levy, O., Waters, C., Fahn, S., Dorovski, T., Chung, W. K., Pauciulo, M. W., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.313 · Cited by 216 · see citing works

Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes

Hong, S., Ostaszewski, B. L., Yang, T., O’Malley, T. T., Jin, M., Yanagisawa, K., Li, S., Bartels, T., & Selkoe, D. J. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.027 · Cited by 213 · see citing works

Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins

Huynh, T.-P. V., Davis, A. A., Ulrich, J. D., & Holtzman, D. M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075481 · Cited by 210 · see citing works

Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers

Susuki, K., Baba, H., Tohyama, K., Kanai, K., Kuwabara, S., Hirata, K., Furukawa, K., Furukawa, K., Rasband, M. N., & Yuki, N. (2007) · Glia · doi:10.1002/glia.20503 · Cited by 197 · see citing works

Structural Transitions Associated with the Interaction of Alzheimer β-Amyloid Peptides with Gangliosides

McLaurin, J., Franklin, T., Fraser, P. E., & Chakrabartty, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4506 · Cited by 188 · see citing works

More than just two peas in a pod: common amyloidogenic properties of tau and α-synuclein in neurodegenerative diseases

Lee, V. M. ‐., Giasson, B. I., & Trojanowski, J. Q. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.01.007 · Cited by 185 · see citing works

The interaction between Alzheimer amyloid β(1–40) peptide and ganglioside GM1‐containing membranes

Choo, L.-P., & Surewicz, W. K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01504-9 · Cited by 178 · see citing works

Role of gangliosides in Alzheimer’s disease

Yanagisawa, K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.01.018 · Cited by 178 · see citing works

Gangliosides of the neuron

Ledeen, R. W. (1985) · Trends in Neurosciences · doi:10.1016/0166-2236(85)90064-5 · Cited by 177 · see citing works

Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans

Wu, G., Lu, Z., Kulkarni, N., & Ledeen, R. W. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23090 · Cited by 164 · see citing works

Characterization of High-Affinity Binding between Gangliosides and Amyloid β-Protein

Ariga, T., Kobayashi, K., Hasegawa, A., Kiso, M., Ishida, H., & Miyatake, T. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2304 · Cited by 158 · see citing works

Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort

de Wilde, A., van der Flier, W. M., Pelkmans, W., Bouwman, F. H., Verwer, J. H., Groot, C., van Buchem, M. M., Zwan, M. D., Ossenkoppele, R., Yaqub, M. M., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1346 · Cited by 151 · see citing works

Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond

Shachar, T., Bianco, C. L., Recchia, A., Wießner, C., Raas‐Rothschild, A., & Futerman, A. H. (2011) · Movement Disorders · doi:10.1002/mds.23774 · Cited by 150 · see citing works

Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies

Chiasserini, D., Paciotti, S., Eusebi, P., Persichetti, E., Tasegian, A., Kurzawa‐Akanbi, M., Chinnery, P. F., Morris, C. M., Calabresi, P., Parnetti, L., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0010-2 · Cited by 149 · see citing works

Ganglioside Molecular Mimicry and Its Pathological Roles in Guillain-Barre Syndrome and Related Diseases

Yu, R. K., Usuki, S., & Ariga, T. (2006) · Infection and Immunity · doi:10.1128/iai.00967-06 · Cited by 143 · see citing works

Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis

Harlalka, G. V., Lehman, A., Chioza, B. A., Baple, E. L., Maroofian, R., Cross, H. E., Sreekantan-Nair, A., Priestman, D. A., Al-Turki, S., McEntagart, M., et al. (2013) · Brain · doi:10.1093/brain/awt270 · Cited by 142 · see citing works

Pathophysiology of neuropathic lysosomal storage disorders

Bellettato, C. M., & Scarpa, M. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9075-9 · Cited by 141 · see citing works

No evidence for substrate accumulation in Parkinson brains with GBA mutations

Gegg, M. E., Sweet, L., Wang, B. H., Shihabuddin, L. S., Sardi, S. P., & Schapira, A. H. V. (2015) · Movement Disorders · doi:10.1002/mds.26278 · Cited by 137 · see citing works

Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

Toledo, J. B., Zetterberg, H., van Harten, A. C., Glodzik, L., Martinez-Lage, P., Bocchio-Chiavetto, L., Rami, L., Hansson, O., Sperling, R., Engelborghs, S., et al. (2015) · Brain · doi:10.1093/brain/awv199 · Cited by 136 · see citing works

Molecular Basis for the Glycosphingolipid-Binding Specificity of α-Synuclein: Key Role of Tyrosine 39 in Membrane Insertion

Fantini, J., & Yahi, N. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.009 · Cited by 129 · see citing works

Alzheimer Disease – Effect of Continuous Intracerebroventricular Treatment with GM1 Ganglioside and a Systematic Activation Programme

Svennerholm, L., Bråne, G., Karlsson, I., Lekman, A., Ramström, I., & Wikkelsö, C. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000063604 · Cited by 126 · see citing works

Signal transduction during amyloid-β-peptide neurotoxicity: role in Alzheimer disease

Fuentealba, R. A., Farı́as, G. G., Scheu, J., Bronfman, M., Marzolo, M., & Inestrosa, N. C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.018 · Cited by 126 · see citing works

Lipids: An insight into the neurodegenerative disorders

Shamim, A., Mahmood, T., Ahsan, F., Kumar, A., & Bagga, P. (2018) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2018.05.001 · Cited by 126 · see citing works

GM1 ganglioside-mediated accumulation of amyloid β-protein on cell membranes

Wakabayashi, M., Okada, T., Kozutsumi, Y., & Matsuzaki, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.060 · Cited by 125 · see citing works

Cortical distribution of gangliosides in Alzheimer's disease

Kraĉun, I., Bognar, S. K., Talan-Hranilović, J., & Ćosović, Č. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90058-y · Cited by 125 · see citing works

Human brain gangliosides in development, aging and disease

Kraĉun, I., Rösner, H., Drnovsek, V., Heffer, M., Cosovi?, C., & Lauc, G. (1991) · The International Journal of Developmental Biology · doi:10.1387/ijdb.1814411 · Cited by 112 · see citing works

Glucocerebrosidase mutations and the pathogenesis of Parkinson disease

Beavan, M. S., & Schapira, A. H. V. (2013) · Annals of Medicine · doi:10.3109/07853890.2013.849003 · Cited by 107 · see citing works

Elevated GM3 plasma concentration in idiopathic Parkinson’s disease: A lipidomic analysis

Chan, R., Perotte, A., Zhou, B., Liong, C., Shorr, E., Marder, K. S., Kang, U. J., Waters, C., Levy, O. A., Xu, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172348 · Cited by 106 · see citing works

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease

Seyfried, T. N., Choi, H. S., Chevalier, A. C., Hogan, D. V., Akgoc, Z., & Schneider, J. S. (2018) · ASN NEURO · doi:10.1177/1759091418781889 · Cited by 102 · see citing works

Increased cholesterol in Aβ-positive nerve terminals from Alzheimer's disease cortex

Gylys, K. H., Fein, J. A., Yang, F., Miller, C. A., & Cole, G. M. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.018 · Cited by 99 · see citing works

GM1 ganglioside and Alzheimer’s disease

Yanagisawa, K. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-015-9579-5 · Cited by 93 · see citing works

GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model

Hadaczek, P., Wu, G., Sharma, N., Ciesielska, A., Bankiewicz, K. S., Davidow, A. L., Lu, Z., Forsayeth, J., & Ledeen, R. W. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.10.010 · Cited by 93 · see citing works

Up-and-down topological mode of amyloid β-peptide lying on hydrophilic/hydrophobic interface of ganglioside clusters

Yagi‐Utsumi, M., Yamaguchi, Y., Sasakawa, H., Yamamoto, N., Yanagisawa, K., & Kato, K. (2008) · Glycoconjugate Journal · doi:10.1007/s10719-008-9216-7 · Cited by 92 · see citing works

How sphingolipids bind and shape proteins: molecular basis of lipid-protein interactions in lipid shells, rafts and related biomembrane domains

Fantini, J. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3003-1 · Cited by 90 · see citing works

Structural characterization of a novel cholinergic neuron-specific ganglioside in bovine brain.

Hirabayashi, Y., Nakao, T., Irie, F., Whittaker, V. P., Kon, K., & Ando, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42369-1 · Cited by 86 · see citing works

Pathophysiological actions of neuropathy‐related anti‐ganglioside antibodies at the neuromuscular junction

Plomp, J. J., & Willison, H. J. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.171702 · Cited by 86 · see citing works

Enhanced capabilities for imaging gangliosides in murine brain with matrix-assisted laser desorption/ionization and desorption electrospray ionization mass spectrometry coupled to ion mobility separation

Škrášková, K., Claude, E., Jones, E. A., Towers, M. W., Ellis, S. R., & Heeren, R. M. A. (2016) · Methods · doi:10.1016/j.ymeth.2016.02.014 · Cited by 84 · see citing works

Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease

Boutin, M., Sun, Y., Shacka, J. J., & Auray‐Blais, C. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04227 · Cited by 82 · see citing works

Gangliosides in Cerebrospinal Fluid in 'Probable Alzheimer's Disease'

Blennow, K., Davidsson, P., Wallin, A., Fredman, P., Gottfries, C. G., Karlsson, I., Månsson, J., & Svennerholm, L. T. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530220048018 · Cited by 81 · see citing works

Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease

der Vlugt, K. G., Langeveld, M., Poppema, A., Kuiper, S., Hollak, C. E. M., Aerts, J. M. F. G., & Groener, J. E. M. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.12.001 · Cited by 77 · see citing works

Electrospray Ionization Ion Mobility Mass Spectrometry of Human Brain Gangliosides

Sârbu, M., Robu, A., Ghiulai, R. M., et al. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b00155 · Cited by 77 · see citing works

Gangliosides determine the amyloid pathology of Alzheimer's disease

Oikawa, N., Yamaguchi, H., Ogino, K., Taki, T., Yuyama, K., Yamamoto, N., Shin, R., Furukawa, K., & Yanagisawa, K. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32832e4b9d · Cited by 74 · see citing works

Gaucher disease and parkinsonism

Sidransky, E. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.11.007 · Cited by 72 · see citing works

Brain Gangliosides in Dementia of the Alzheimer Type

Crino, P. B., Ullman, M. D., Vogt, B. A., Bird, E. D., & Volicer, L. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520400054019 · Cited by 71 · see citing works

Coupling of fully automated chip-based electrospray ionization to high-capacity ion trap mass spectrometer for ganglioside analysis

Almeida, R., Moşoarcă, C., Chirita, M., et al. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.03.039 · Cited by 70 · see citing works

Gene-Wise Association of Variants in Four Lysosomal Storage Disorder Genes in Neuropathologically Confirmed Lewy Body Disease

Clark, L. N., Chan, R., Cheng, R., Liu, X., Park, N., Parmalee, N. L., Kisselev, S., Cortes, E. P., Torres, P., Pastores, G. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125204 · Cited by 67 · see citing works

Pathological role of lipid interaction with α-synuclein in Parkinson's disease

Suzuki, M., Sango, K., Wada, K., & Nagai, Y. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.12.014 · Cited by 67 · see citing works

GM1-ganglioside-induced Aβ assembly on synaptic membranes of cultured neurons

Yamamoto, N., Fukata, Y., Fukata, M., & Yanagisawa, K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.01.009 · Cited by 63 · see citing works

Anti-inflammatory mechanism of exogenous C2 ceramide in lipopolysaccharide-stimulated microglia

Jung, J.-S., Shin, K., Lee, Y.-M., Shin, J. A., Park, E., Jeong, J.-J., Kim, D., Choi, J. W., & Kim, H.-S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.01.020 · Cited by 62 · see citing works

Microglial Lectins in Health and Neurological Diseases

Siew, J. J., & Chern, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00158 · Cited by 61 · see citing works

Gangliosides' analysis by MALDI-ion mobility MS

Jackson, S. N., Colsch, B., Egan, T. F., et al. (2010) · The Analyst · doi:10.1039/c0an00732c · Cited by 60 · see citing works

Natural Product Glycosyltransferases: Properties and Applications

Williams, G. J., & Thorson, J. S. (2009) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470392881.ch2 · Cited by 60 · see citing works

GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology

Michno, W., Wehrli, P. M., Zetterberg, H., Blennow, K., & Hanrieder, J. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.09.010 · Cited by 59 · see citing works

Altered Distribution of the Gangliosides GM1 and GM2 in Alzheimer’s Disease

Pernber, Z., Blennow, K., Bogdanović, N., Månsson, J., & Blomqvist, M. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000338181 · Cited by 58 · see citing works

Deciphering the Glycolipid Code of Alzheimer's and Parkinson's Amyloid Proteins Allowed the Creation of a Universal Ganglioside-Binding Peptide

Yahi, N., & Fantini, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104751 · Cited by 58 · see citing works

GM1 Ganglioside and the Seeding of Amyloid in Alzheimer’s Disease: Endogenous Seed for Alzheimer Amyloid

Yanagisawa, K. (2005) · The Neuroscientist · doi:10.1177/1073858405275177 · Cited by 55 · see citing works

Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease

Foley, P., Bradford, H. F., Docherty, M., et al. (1988) · Journal of Neurology · doi:10.1007/bf00314249 · Cited by 54 · see citing works

Combination of ESI and MALDI mass spectrometry for qualitative, semi-quantitative and in situ analysis of gangliosides in brain

Zhang, Y., Wang, J., Liu, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25289 · Cited by 53 · see citing works

Lipidomics of Alzheimer’s Disease

Touboul, D., & Gaudin, M. (2014) · Bioanalysis · doi:10.4155/bio.13.346 · Cited by 52 · see citing works

Antibodies to Cholinergic Neurons in Alzheimer's Disease

Chapman, J., Bachar, O., Korczyn, A. D., Wertman, E., & Michaelson, D. M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01063.x · Cited by 51 · see citing works

Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation

Luan, K., Rosales, J. L., & Lee, K. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.002 · Cited by 51 · see citing works

Antibodies to ganglioside GM1 in patients with Alzheimer's disease

Chapman, J., Sela, B., Wertman, E., et al. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90577-0 · Cited by 50 · see citing works

Regional distribution of brain gangliosides in Alzheimer's disease.

Bognar, S. K., Kraĉun, I., Rösner, H., & Ćosović, Č. (1991) · PubMed · Cited by 49 · see citing works

High‐performance separation techniques hyphenated to mass spectrometry for ganglioside analysis

Şişu, E., Flangea, C., Serb, A. F., Rizzi, A. M., & Zamfir, A. D. (2011) · Electrophoresis · doi:10.1002/elps.201100067 · Cited by 49 · see citing works

Current Organic Chemistry

(2019) · Current Organic Chemistry · doi:10.2174/coc-13852728-596 · Cited by 49 · see citing works

Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of Aβ Toxicity and Stroke

Caughlin, S., Hepburn, J. D., Park, D. H., Jurčić, K., Yeung, K. K. ‐., Cechetto, D. F., & Whitehead, S. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130364 · Cited by 48 · see citing works

Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease

Kodama, T., Togawa, T., Tsukimura, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029074 · Cited by 47 · see citing works

Gangliosides and Sialylcholesterol as Modulators of Synaptic Functionsa

ANDO, S., Tanaka, Y., Waki, H., et al. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09676.x · Cited by 46 · see citing works

A world of sphingolipids and glycolipids in the brain —Novel functions of simple lipids modified with glucose—

Hirabayashi, Y. (2012) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.88.129 · Cited by 45 · see citing works

Imbalance in Fatty-Acid-Chain Length of Gangliosides Triggers Alzheimer Amyloid Deposition in the Precuneus

Oikawa, N., Matsubara, T., Fukuda, R., Yasumori, H., Hatsuta, H., Murayama, S., Sato, T., Suzuki, A., & Yanagisawa, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121356 · Cited by 44 · see citing works

Advances in Chromatography

(2010) · Advances in chromatography · doi:10.1201/crcadvchroma · Cited by 43 · see citing works

High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson’s Disease Patients

Zhang, J., Zhang, X., Wang, L., & Yang, C. (2017) · Medical Science Monitor · doi:10.12659/msm.904399 · Cited by 42 · see citing works

Alzheimer's disease is associated with disordered localization of ganglioside GM1 molecular species in the human dentate gyrus

Hirano, W., Sugiyama, E., Hayasaka, T., Ravid, R., Setou, M., & Taki, T. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.09.033 · Cited by 40 · see citing works

Sample preparation and orthogonal chromatography for broad polarity range plasma metabolomics: Application to human subjects with neurodegenerative dementia

Armirotti, A., Basit, A., Realini, N., et al. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.03.019 · Cited by 39 · see citing works

Plasma lipids are altered in Gaucher disease: biochemical markers to evaluate therapeutic intervention.

Meikle, P., Whitfield, P., Rozaklis, T., Blacklock, D., Duplock, S., Elstein, D., Zimran, A., Mengel, E., Cannell, P., Hopwood, J., et al. (2008) · Blood Cells, Molecules & Diseases · doi:10.1016/j.bcmd.2007.10.004 · Cited by 38 · see citing works

Congenital Disorders of Ganglioside Biosynthesis

Li, T. A., & Schnaar, R. L. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.01.001 · Cited by 38 · see citing works

Ion mobility mass spectrometry provides novel insights into the expression and structure of gangliosides in the normal adult human hippocampus

Sârbu, M., Vukelić, Ž., Clemmer, D. E., et al. (2018) · The Analyst · doi:10.1039/c8an01118d · Cited by 37 · see citing works

Gangliosides in the brain in adult Down’s syndrome and Alzheimer’s disease

Brooksbank, B. W. L., & McGovern, J. (1989) · Molecular and Chemical Neuropathology · doi:10.1007/bf03160048 · Cited by 34 · see citing works

Neurological Analyses: Focus on Gangliosides and Mass Spectrometry

Zamfir, A. D. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-06068-2_8 · Cited by 34 · see citing works

Ganglioside Metabolism in a Transgenic Mouse Model of Alzheimer’s Disease: Expression of Chol-1α Antigens in the Brain

Ariga, T., Yanagisawa, M., Wakade, C. G., Ando, S., Buccafusco, J. J., McDonald, M. P., & Yu, R. K. (2010) · ASN NEURO · doi:10.1042/an20100021 · Cited by 33 · see citing works

The 11‐mer repeats of human α‐synuclein in vesicle interactions and lipid composition discrimination: A cooperative role

Bisaglia, M., Schievano, E., Caporale, A., Peggion, E., & Mammi, S. (2006) · Biopolymers · doi:10.1002/bip.20440 · Cited by 33 · see citing works

Brain Gangliosides in Alzheimer’s Disease: Increased Expression of Cholinergic Neuron-Specific Gangliosides

Fukami, Y., Ariga, T., Yamada, M., & Yuki, N. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170117094038 · Cited by 32 · see citing works

Assessment of ganglioside age-related and topographic specificity in human brain by Orbitrap mass spectrometry

Sârbu, M., Dehelean, L., Munteanu, C. V. A., et al. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.01.010 · Cited by 31 · see citing works

Membrane Glycolipids: Functional Heterogeneity: A Review

Malhotra, R. (2012) · Biochemistry & Analytical Biochemistry · doi:10.4172/2161-1009.1000108 · Cited by 29 · see citing works

GM1 ganglioside: another nuclear lipid that modulates nuclear calcium. GM1 potentiates the nuclear sodium–calcium exchangerThis paper is one of a selection of papers published in this Special Issue, entitled The Nucleus: A Cell Within A Cell.

Ledeen, R. W., & Wu, G. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-133 · Cited by 28 · see citing works

Alterations in Cholesterol and Ganglioside GM1 Content of Lipid Rafts in Platelets From Patients With Alzheimer Disease

Liu, L., Zhang, K., Tan, L. J., Chen, Y., & Cao, Y. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000041 · Cited by 28 · see citing works

Ganglioside Metabolism and Parkinson's Disease

Forsayeth, J., & Hadaczek, P. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00045 · Cited by 27 · see citing works

Modern separation techniques coupled to high performance mass spectrometry for glycolipid analysis

Sârbu, M., & Zamfir, A. D. (2018) · Electrophoresis · doi:10.1002/elps.201700461 · Cited by 26 · see citing works

Conformationally Regulated Peptide Bond Cleavage in Bradykinin

Fuller, D. R., Conant, C. R., El‐Baba, T. J., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b04751 · Cited by 26 · see citing works

Melting proteins confined in nanodroplets with 10.6 μm light provides clues about early steps of denaturation

El‐Baba, T. J., Fuller, D. R., Woodall, D. W., et al. (2018) · Chemical Communications · doi:10.1039/c7cc09829d · Cited by 25 · see citing works

Mass spectrometry of gangliosides in extracranial tumors: Application to adrenal neuroblastoma

Robu, A., Vukelić, Ž., Schiopu, C., et al. (2016) · Analytical Biochemistry · doi:10.1016/j.ab.2016.06.005 · Cited by 24 · see citing works

Quantification of monosialogangliosides in human plasma through chemical derivatization for signal enhancement in LC–ESI-MS

Huang, Q., Liu, D., Xin, B., Cechner, K., Zhou, X., Wang, H., & Zhou, A. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.04.043 · Cited by 23 · see citing works

Antibodies to fucogangliosides in neurological diseases

Yuki, N., & Ariga, T. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)05392-6 · Cited by 18 · see citing works

Glycosylation Analysis of Proteins, Proteoglycans, and Glycolipids Using Capillary Electrophoresis and Mass Spectrometry.

Zamfir, A., Flangea, C., Altmann, F., & Rizzi, A. (2011) · Advances in Chromatography · doi:10.1201/b10721-5 · Cited by 18 · see citing works

Clinical diversity in Gaucher's disease.

Gh, S. (1980) · PubMed · Cited by 16 · see citing works

Advances in Enzymology and Related Areas of Molecular Biology

(1979) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470122938 · Cited by 16 · see citing works

Total glycolipid and glucosylceramide content in serum and urine of patients with Gaucher's disease type 3 before and after enzyme replacement therapy

Gornati, R., Bembi, B., Tong, X., et al. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)00241-6 · Cited by 14 · see citing works

Autoantibodies to GM1 and GQ1bα are not Biological Markers of Alzheimer's Disease

Miura, Y., Miyaji, K., Chai, Y. L., Chen, C., Lai, M. K. P., & Yuki, N. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140474 · Cited by 13 · see citing works

Glycolipids: Distribution and Biological Function

Brandenburg, K., & Holst, O. (2015) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0001427.pub3 · Cited by 9 · see citing works

The intrinsically disordered N-terminal arm of the brome mosaic virus coat protein specifically recognizes the RNA motif that directs the initiation of viral RNA replication

Jacobs, A. D., Hoover, H., Smith, E. S. C., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1087 · Cited by 8 · see citing works

B Subunit Monomers of Cholera Toxin Bind G1 Ganglioside Class as Revealed by Chip-Nanoelectrospray Multistage Mass Spectrometry

Căpitan, F., Robu, A., Popescu, L., et al. (2015) · Journal of Carbohydrate Chemistry · doi:10.1080/07328303.2015.1085061 · Cited by 7 · see citing works

Ganglioside catabolism is altered in fibroblasts and leukocytes from Alzheimer's disease patients

Bognar, S. K. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.012 · Cited by 6 · see citing works

Quantification of glucosylceramide in plasma of Gaucher disease patients

Muller, M. V. G., Petry, A., Vianna, L. P., Breier, A. C., Michelin-Tirelli, K., Pires, R., Trindade, V. M. T., & Coelho, J. (2010) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502010000400005 · Cited by 5 · see citing works

High Levels of Anti-Ganglioside Antibodies in Patients with Parkinson?s Disease Associated with Cognitive Decline

M, H. E. A. (2015) · International Journal of Neurorehabilitation · doi:10.4172/2376-0281.1000159 · Cited by 4 · see citing works

Measurements of the stabilities of isolated retinal chromophores

Musbat, L., Nihamkin, M., Toker, Y., et al. (2017) · Physical review. E · doi:10.1103/physreve.95.012406 · Cited by 3 · see citing works

ApoE and Lipid Homeostasis in Alzheimer's Disease Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-.BETA. and other amyloidogenic proteins

Tien‐Phat, V. H., Albert, A., Jason, D., & David, M. H. (2017) · Journal of Lipid Research · Cited by 3 · see citing works

Structural analysis by electrospray ionization mass spectrometry of GT1 ganglioside fraction isolated from fetal brain

Cozma, I. I., Sârbu, M., Ilie, C., et al. (2017) · Journal of Carbohydrate Chemistry · doi:10.1080/07328303.2017.1397680 · Cited by 3 · see citing works

Structure-to-function Relationship of Carbohydrates in the Mechanism of Lysosomal Storage Disorders (LSDs)

Sârbu, M., Cozma, C., & Zamfir, A. D. (2018) · Current Organic Chemistry · doi:10.2174/1385272821666170428124638 · Cited by 2 · see citing works

GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review

De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20 · see citing works

Abnormally high levels of oxidized DJ-1 in cases of Parkinson’s disease (PD) and dementia with lewy bodies (DLB)

Saigoh, K., Yamagishi, Y., Saito, Y., et al. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.2187 · Cited by 2 · see citing works

Differences and similarities between Lewy body dementia and Parkinson's disease dementia

Laar, V. T. (2006) · University of Groningen research database (University of Groningen / Centre for Information Technology)

Quality of Life and the Effect of Memantine in Dementia with Lewy Bodies and Parkinson’s Disease Dementia

Larsson, V., Engedal, K., Aarsland, D., Wattmo, C., Minthon, L., & Londos, E. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000334523 · Cited by 50 · see citing works

Role of Inflammation in Lewy Body Dementia

Surendranathan, A., & O'Brien, J. T. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108539623.011

Updates in diagnosis and treatment of dementia with Lewy body

(2022) · Medical Sciences · doi:10.53453/ms.2022.07.5